Research Article| Volume 1, ISSUE 1, P67-76, March 1981

Blood Banking

  • Paul M. Ness
    The Johns Hopkins Hospital 600 North Wolfe Street Baltimore, Maryland 21205.
    Director, Blood Bank; Assistant Professor, Pathology, Medicine, and Oncology, The Johns Hopkins Hospital, Baltimore, Maryland
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      In no other branch of laboratory medicine has improved technology so quickly demonstrated clinical benefit as it has in blood banking. A major consequence of this explosive growth has been to bring the blood banker into the clinical forefront to assist the clinician in selecting the appropriate product for his patient and in interpreting the results of laboratory determinations. A discussion of several blood components and procedures illustrates the dilemmas faced in blood banking today.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alter H.J.
        • Tabor E.
        • Meryman H.T.
        • et al.
        Transmission of hepatitis B vims infection by transfusion of frozen-deglycerolized red blood cells.
        N. Engl. J. Med. 1978; 298: 637
        • Boral L.I.
        • Henry J.B.
        The type and screen: A safe alternative and supplement in selected surgical procedures.
        Transfusion. 1977; 17: 163
        • Bove J.R.
        Fibrinogen—is the benefit worth the risk?.
        Transfusion. 1978; 18: 129
        • Chaplin H.
        • Beutler E.
        • Collins J.A.
        • et al.
        Current status of red cell preservation and availability in relation to the developing national blood policy.
        N. Engl. f. Med. 1974; 291: 68
        • Giblett E.R.
        Blood group alloantibodies: An assessment of some laboratory practices.
        Transfusion. 1977; 17: 299
        • Haugan R.K.
        Hepatitis after the transfusion of frozen red cells and washed red cells.
        N. Engl. J. Med. 1979; 301: 393
        • Higby D.J.
        • Burnett D.
        Granulocyte transfusions: Current status.
        Blood. 1980; 55: 2
        • Klock J.L.
        • Bainton D.F.
        Degranulation and abnormal bactericidal function of granulo cytes procured by reversible adhesion nylon wool.
        Blood. 1976; 48: 149
        • Landsteiner K.
        Zur Kenntris der antifermentativen, lytischen, und agglutinierenden Wirkun gen des Blutserums und der Lymphe.
        Zbl. Bakt. 1901; 27: 357
        • Leikoka J.
        • Perkins H.A.
        Enzyme linked antiglobulin test: An accurate and simple method to quantify red cell antibodies.
        Transfusion. 1980; 20: 138
        • Lenny L.
        • Goldstein J.
        Enzymatic removal of blood group B antigen from gibbon erythrocytes.
        Transfusion. 1980; 20: 618
        • Levine E.M.
        • Friedman A.E.
        Artificial blood on the laboratory horizon.
        Lab. World. 1980; 31: 56
        • Lewisohn R.
        Blood transfusion by the citrate method.
        Surg. Gynecol. Obstet. 1915; 21: 37
        • Loutit J.F.
        • Mollison P.L.
        Advantages of a disodium-citrate-glucose mixture as a blood preservative.
        Brit. Med. J. 1943; 2: 744
        • McGill M.
        Platelet concentrate storage: Temperature and centrifugation have significant effects on function.
        Transfusion. 1979; 19: 661
        • Meryman H.T.
        • Bross J.
        • Lebovitz R.
        The preparation of leukocyte-poor red blood cells: A comparative study.
        Transfusion. 1980; 20: 285
        • Mintz P.D.
        • Hawes A.
        • Sullivan M.
        Incompatible crossmatch following negative antibody screen: Frequency and cause.
        Transfusion. 1980; 20: 651
      1. Ness, P. M., Frey, E., and Perkins, H. A.: Improved blood utilization with leukocyte poor cell masses (LPCM) prepared by cell washing. Transfusion, in press

        • Ness P.M.
        • Pennington R.M.
        Plasma fractionation in the United States: A review for clinicians.
        J.A.M.A. 1974; 230: 247
        • Ness P.M.
        • Perkins H.A.
        Therapeutic complications in acute myelogenous leukemia.
        N. Engl. J. Med. 1979; 301: 557
        • Ness P.M.
        • Stengle J.M.
        Historical introduction.
        in: Surgenor D.M. The Red Blood Cells. Academic Press, New York1974
        • Opelz G.
        • Terasaki P.I.
        Poor kidney transplant survival in recipients with frozen blood transfusions or no transfusion.
        Lancet. 1974; 2: 696
        • Schiffer C.A.
        • Aisner J.
        • Daly P.A.
        • et al.
        Alloimmunization following prophylactic granulocyte transfusion.
        Blood. 1979; 54: 766
        • Schiffer C.A.
        • Bucholz D.H.
        • Aisner J.
        • et al.
        Frozen autologous platelets in the supportive care of patients with leukemia.
        Transfusion. 1976; 16: 321
        • Schmidt P.J.
        Red cells for transfusion.
        N. Engl. J. Med. 1978; 299: 1411
        • Silvergleid A.J.
        • Wells R.F.
        • Hafleigh E.B.
        • et al.
        Compatibility test using 51Cr-labelled red blood cells in crossmatch positive patients.
        Transfusion. 1978; 18: 8
        • Solomon J.
        • Beutler E.
        • Bofenkamp R.
        • et al.
        Indications for the administration of platelet transfusions during remission induction therapy of acute leukemia (abstracted).
        Blood. 1977; 50: 210
        • Spero J.A.
        • Lewis J.H.
        • Van Thiel D.H.
        • et al.
        A symptomatic structural liver disease in hemophilia.
        N. Engl. J. Med. 1978; 293: 1373
        • Valeri C.R.
        • Zaroulis C.G.
        Rejuvenation and freezing of outdated stored human red cells.
        N. Engl. J. Med. 1972; 287: 1307
        • Walter C.W.
        • Murphy Jr., W.P.
        A closed gravity technique for the preservation of whole blood in ACD solution utilizing plastic equipment.
        Surg. Gynecol. Obstet. 1952; 94: 687
        • Winn L.C.
        • Svoboda R.
        • Hafleigh E.B.
        • et al.
        An extended antibody screen to replace the crossmatch.
        Transfusion. 1980; 20: 651
        • Winston D.J.
        • Ho W.G.
        • Howell C.L.
        • et al.
        Cytomegalovirus infections associated with leukocyte transfusions.
        Ann. Intern. Med. 1980; 93: 671
        • Wooten M.J.O.
        Use and analysis of saline washed red blood cells.
        Transfusion. 1976; 16: 464